OFI Invest Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5M Hold
500,000
0.29% 79
2026
Q1
$27.3M Buy
+500,000
New +$34.8M 0.36% 74
2025
Q4
Sell
-1,549
Closed -$88.7K 378
2025
Q3
$88.7K Buy
1,549
+41
+3% +$3.25K ﹤0.01% 290
2025
Q2
$112K Buy
1,508
+591
+64% +$46.3K ﹤0.01% 210
2025
Q1
$58K Buy
917
+281
+44% +$22.9K ﹤0.01% 332
2024
Q4
$47.8K Buy
+636
New +$47.1K ﹤0.01% 290
2024
Q2
$13.7M Buy
129,387
+129,144
+53,146% +$16.3M 0.36% 66
2024
Q1
$31.2K Sell
243
-35
-13% -$4.4K ﹤0.01% 235
2023
Q4
$31.2K Sell
278
-6
-2% -$613 ﹤0.01% 189
2023
Q3
$25K Buy
+284
New +$32K ﹤0.01% 209

Other funds holding DXCM

OFI Invest Asset Management's DXCM Position: Q2 2026 in Review

OFI Invest Asset Management held its DexCom (DXCM) position steady in Q2 2026 at 500,000 shares worth $29.5M. The position accounts for 0.29% of the portfolio, ranked #79.

OFI Invest Asset Management first reported a position in DXCM in Q3 2023 and has held it in 10 quarters since. 530 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • OFI Invest Asset Management held 500,000 shares of DexCom worth $29.5M as of Q2 2026.
  • OFI Invest Asset Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.29% of OFI Invest Asset Management's portfolio in Q2 2026, its #79 holding.
  • OFI Invest Asset Management first reported a position in DexCom in Q3 2023 and has held it in 10 quarters since.
  • 530 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.